University Hospitals Bristol NHS Foundation Trust-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia

    Blood Cancer Journal